Skip to content

Clinical trials

Expanded access trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Country / region: Greece Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20051
20062

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Approved for marketing10
No longer available6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer3
Boehringer Ingelheim2
Novartis Pharmaceuticals2
Tibotec Pharmaceuticals, Ireland2
Bayer1
Eisai Inc.1
Eli Lilly and Company1
Gilead Sciences1
Janssen-Cilag International NV1
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Infections3
Breast Neoplasms1
COVID-191
Carcinoma, Renal Cell1
Colorectal Neoplasms1
Dermatitis, Atopic1
Eczema1
Gastrointestinal Neoplasms1
Genital Diseases, Male1
Genital Neoplasms, Male1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.